March 15, 2022
NexImmune Announces Melanoma Research Collaboration with NYU Langone’s Perlmutter Cancer Center
GAITHERSBURG, MD, March 14, 2022 (GLOBE NEWSWIRE) -- NexImmune, Inc. (Nasdaq: NEXI), a clinical-stage biotechnology company…
March 15, 2022
SXSW 2022 Announces Winners of 14th Annual Pitch Event
“What do you envision for your company’s future?” is a typical question for startups. And…
March 14, 2022
Dr. Ken Malone, Co-Founder and Managing Director of Early Charm Ventures, Visits BioTalk
Ken Malone, Co-Founder and Managing Director of Early Charm Ventures, Joins BioTalk to discuss his…
March 14, 2022
Dr. Ken Malone, Co-Founder and Managing Director of Early Charm Ventures, Visits BioTalk
Ken Malone, Co-Founder and Managing Director of Early Charm Ventures, Joins BioTalk to discuss his…
March 14, 2022
Emergent BioSolutions Initiates Phase 1 Study Evaluating Potential Intranasal Treatment for Cyanide Poisoning
GAITHERSBURG, Md., March 11, 2022 (GLOBE NEWSWIRE) -- Emergent BioSolutions Inc. (NYSE: EBS) today announced that it has dosed…